Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1951)
Medline Inc. (MDLN)
BCP 8 Holdings Mozart Manager L.L.C. — 10% Owner
Shares
1,245,544
Price
$40.51
Total Value
$50.45M
Shares Held After
1,539
% of Holdings
99.9%
Medline Inc. (MDLN)
BCP 8 Holdings Mozart Manager L.L.C. — 10% Owner
Shares
1,886,636
Price
$40.51
Total Value
$76.42M
Shares Held After
12,507,704
% of Holdings
13.1%
Medline Inc. (MDLN)
BCP 8 Holdings Mozart Manager L.L.C. — 10% Owner
Shares
8,241,723
Price
$40.51
Total Value
$333.86M
Shares Held After
10,185
% of Holdings
99.9%
Medline Inc. (MDLN)
BCP 8 Holdings Mozart Manager L.L.C. — 10% Owner
Shares
16,479,083
Price
$40.51
Total Value
$667.53M
Shares Held After
109,250,239
% of Holdings
13.1%
Medline Inc. (MDLN)
BX Mozart ML-2 Holdco L.P. — 10% Owner
Shares
1,245,544
Price
$40.51
Total Value
$50.45M
Shares Held After
1,539
% of Holdings
99.9%
Medline Inc. (MDLN)
BX Mozart ML-2 Holdco L.P. — 10% Owner
Shares
1,886,636
Price
$40.51
Total Value
$76.42M
Shares Held After
12,507,704
% of Holdings
13.1%
Medline Inc. (MDLN)
BX Mozart ML-2 Holdco L.P. — 10% Owner
Shares
8,241,723
Price
$40.51
Total Value
$333.86M
Shares Held After
10,185
% of Holdings
99.9%
Medline Inc. (MDLN)
BX Mozart ML-2 Holdco L.P. — 10% Owner
Shares
16,479,083
Price
$40.51
Total Value
$667.53M
Shares Held After
109,250,239
% of Holdings
13.1%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
8,671
Price
$72.00
Total Value
$624.31K
Shares Held After
7,465
% of Holdings
53.7%
Medline Inc. (MDLN)
TC Group Cayman Investment Holdings, L.P. — 10% Owner
Shares
26,105,840
Price
$41.00
Total Value
$1.07B
Shares Held After
127,567,724
% of Holdings
17.0%
Medline Inc. (MDLN)
Carlyle Mozart Coinvestment Holdings, L.P. — 10% Owner
Shares
26,105,840
Price
$41.00
Total Value
$1.07B
Shares Held After
127,567,724
% of Holdings
17.0%
Medline Inc. (MDLN)
CP Circle ML Holdco GP, LLC — 10% Owner
Shares
26,105,840
Price
$41.00
Total Value
$1.07B
Shares Held After
127,567,724
% of Holdings
17.0%
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Christianson Mark — Business Development Director
Shares
11,611
Price
$0.80
Total Value
$9.29K
Shares Held After
217,309
% of Holdings
5.1%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$22.12
Total Value
$22.12K
Shares Held After
37,415
% of Holdings
2.7%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
2,300
Price
$9.21
Total Value
$21.18K
Shares Held After
67,419
% of Holdings
3.3%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
2,299
Price
$8.93
Total Value
$20.53K
Shares Held After
69,719
% of Holdings
3.2%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
2,531
Price
$9.21
Total Value
$23.31K
Shares Held After
69,796
% of Holdings
3.5%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
2,530
Price
$8.93
Total Value
$22.59K
Shares Held After
72,327
% of Holdings
3.4%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
281,858
Price
$19.80
Total Value
$5.58M
Shares Held After
4,774,058
% of Holdings
5.6%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
219,758
Price
$19.32
Total Value
$4.25M
Shares Held After
5,055,916
% of Holdings
4.2%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
9,482
Price
$18.21
Total Value
$172.69K
Shares Held After
5,275,674
% of Holdings
0.2%
Avantor, Inc. (AVTR)
MEHRA SANJEEV K — Director
Shares
125,000
Price
$8.01
Total Value
$1.00M
Shares Held After
475,000
% of Holdings
26.3%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
17,591
Price
$76.34
Total Value
$1.34M
Shares Held After
242,662
% of Holdings
6.8%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
16,512
Price
$75.47
Total Value
$1.25M
Shares Held After
260,253
% of Holdings
6.0%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
11,388
Price
$13.02
Total Value
$148.22K
Shares Held After
121,510
% of Holdings
8.6%
HENRY SCHEIN INC (HSIC)
KUEHN KURT P — Director
Shares
2,844
Price
$78.96
Total Value
$224.57K
Shares Held After
15,420
% of Holdings
15.6%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
10,129
Price
$30.19
Total Value
$305.83K
Shares Held After
25,000
% of Holdings
28.8%
IONIS PHARMACEUTICALS INC (IONS)
Jenne Kyle — EVP, Chf GL Pdt Str Ofcr
Shares
16,086
Price
$76.30
Total Value
$1.23M
Shares Held After
11,714
% of Holdings
57.9%
IONIS PHARMACEUTICALS INC (IONS)
Jenne Kyle — EVP, Chf GL Pdt Str Ofcr
Shares
21,191
Price
$75.50
Total Value
$1.60M
Shares Held After
27,800
% of Holdings
43.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$548.10
Total Value
$65.77K
Shares Held After
130
% of Holdings
48.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$547.14
Total Value
$218.86K
Shares Held After
250
% of Holdings
61.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$546.21
Total Value
$262.18K
Shares Held After
650
% of Holdings
42.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
936
Price
$545.05
Total Value
$510.17K
Shares Held After
1,130
% of Holdings
45.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$544.04
Total Value
$448.29K
Shares Held After
2,066
% of Holdings
28.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$542.88
Total Value
$304.01K
Shares Held After
2,890
% of Holdings
16.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$541.69
Total Value
$216.68K
Shares Held After
3,450
% of Holdings
10.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$540.63
Total Value
$237.88K
Shares Held After
3,850
% of Holdings
10.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,351
Price
$539.84
Total Value
$729.32K
Shares Held After
4,290
% of Holdings
23.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
563
Price
$539.02
Total Value
$303.47K
Shares Held After
5,641
% of Holdings
9.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
647
Price
$537.92
Total Value
$348.04K
Shares Held After
6,204
% of Holdings
9.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$535.99
Total Value
$246.02K
Shares Held After
6,851
% of Holdings
6.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$535.09
Total Value
$706.32K
Shares Held After
7,310
% of Holdings
15.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$533.23
Total Value
$21.33K
Shares Held After
8,630
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$531.54
Total Value
$21.26K
Shares Held After
8,670
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$530.49
Total Value
$63.66K
Shares Held After
8,710
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$530.03
Total Value
$424.02K
Shares Held After
8,830
% of Holdings
8.3%
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
11,894
Price
$13.05
Total Value
$155.19K
Shares Held After
198,588
% of Holdings
5.7%
Fortrea Holdings Inc. (FTRE)
Parks Robert — Chief Accounting Officer
Shares
964
Price
$9.21
Total Value
$8.88K
Shares Held After
22,389
% of Holdings
4.1%
Fortrea Holdings Inc. (FTRE)
Parks Robert — Chief Accounting Officer
Shares
963
Price
$8.93
Total Value
$8.60K
Shares Held After
23,353
% of Holdings
4.0%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
5,623
Price
$204.13
Total Value
$1.15M
Shares Held After
156,607
% of Holdings
3.5%
Showing 751–800 of 1951 transactions (page 16 of 40)